Works matching IS 08876924 AND DT 2009 AND VI 23 AND IP 1

Results: 36

Spotlight review series on multiple myeloma.

Published in:

2009

By:

Rajkumar, S V;
Killmann, N M-B

Publication type:

Editorial

5-Azacitidine has limited therapeutic activity in myelofibrosis.

Published in:

2009

By:

Mesa, R A;
Verstovsek, S;
Rivera, C;
Pardanani, A;
Hussein, K;
Lasho, T;
Wu, W;
Tefferi, A

Publication type:

clinical trial

Reply to ‘The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rates in hematologic malignancy patients: outcome of a pilot clinical study’ by Ning et al.

Published in:

2009

By:

Behre, G;
Theurich, S;
Weber, T;
Christopeit, M

Publication type:

Letter

Reply to “Reply to ‘The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rates in hematologic malignancy patients: outcome of a pilot clinical study’ by Ning H et al.” by Behre et al.

Published in:

2009

By:

Ning, H;
Yang, F;
Jiang, M;
Hu, L;
Feng, K;
Zhang, J;
Yu, Z;
Li, B;
Xu, C;
Li, Y;
Wang, J;
Hu, J;
Lou, X;
Chen, H

Publication type:

Letter

Improving the prognostic evaluation of patients with lower risk myelodysplastic syndromes.

Published in:

2009

By:

Kuendgen, A;
Gattermann, N;
Germing, U

Publication type:

Letter

MicroRNAs and deletion of the derivative chromosome 9 in chronic myeloid leukemia.

Published in:

2009

By:

Chaubey, A;
Karanti, S;
Rai, D;
Oh, T;
Adhvaryu, S G;
Aguiar, R C T

Publication type:

Letter

In reply to ‘Improving the prognostic evaluation of patients with lower-risk myelodysplastic syndromes’ by Kuendgen et al.

Published in:

2009

By:

Garcia-Manero, G

Publication type:

Letter

Transient depletion of RUNX1/RUNX1T1 by RNA interference delays tumour formation in vivo.

Published in:

2009

By:

Soria, N Martinez;
Tussiwand, R;
Ziegler, P;
Manz, M G;
Heidenreich, O

Publication type:

Letter

Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive acute lymphoblastic leukemia.

Published in:

2009

By:

Shimoni, A;
Leiba, M;
Schleuning, M;
Martineau, G;
Renaud, M;
Koren-Michowitz, M;
Ribakovski, E;
le Coutre, P;
Arnold, R;
Guilhot, F;
Nagler, A

Publication type:

Letter

Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a ‘donor’ versus ‘no donor’ comparison.

Published in:

2009

By:

Mohty, M;
de Lavallade, H;
El-Cheikh, J;
Ladaique, P;
Faucher, C;
Fürst, S;
Vey, N;
Coso, D;
Stoppa, A-M;
Gastaut, J-A;
Chabannon, C;
Blaise, D

Publication type:

Letter

Molecular insights into the morphology of myeloproliferative neoplasms using an in situ PCR assay specific for the JAK2 mutation V617F.

Published in:

2009

By:

Gattenlohner, S;
Serfling, E;
Einsele, H;
Müller-Hermelink, H K

Publication type:

Letter

Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family.

Published in:

2009

By:

Cazzaniga, G;
Lo Nigro, L;
Cifola, I;
Milone, G;
Schnittger, S;
Haferlach, T;
Mirabile, E;
Costantino, F;
Martelli, M P;
Mastrodicasa, E;
Di Raimondo, F;
Aversa, F;
Biondi, A;
Falini, B

Publication type:

Letter

TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis.

Published in:

2009

By:

Bowen, D;
Groves, M J;
Burnett, A K;
Patel, Y;
Allen, C;
Green, C;
Gale, R E;
Hills, R;
Linch, D C

Publication type:

Letter

Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling.

Published in:

2009

By:

Cardoso, B A;
Martins, L R;
Santos, C I;
Nadler, L M;
Boussiotis, V A;
Cardoso, A A;
Barata, J T

Publication type:

Letter

Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids.

Published in:

2009

By:

Lönnerholm, G;
Nordgren, A;
Frost, B-M;
Jonsson, O G;
Kanerva, J;
Nygaard, R;
Schmiegelow, K;
Larsson, R;
Forestier, E

Publication type:

Letter

Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.

Published in:

2009

By:

Misaghian, N;
Ligresti, G;
Steelman, L S;
Bertrand, F E;
Bäsecke, J;
Libra, M;
Nicoletti, F;
Stivala, F;
Milella, M;
Tafuri, A;
Cervello, M;
Martelli, A M;
McCubrey, J A;
Bäsecke, J

Publication type:

journal article

Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors.

Published in:

Leukemia (08876924), 2009, v. 23, n. 1, p. 162, doi. 10.1038/leu.2008.255

By:

Negaard, H F S;
Iversen, N;
Bowitz-Lothe, I M;
Sandset, P M;
Steinsvik, B;
Østenstad, B;
Iversen, P O

Publication type:

Article

Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases.

Published in:

Leukemia (08876924), 2009, v. 23, n. 1, p. 85, doi. 10.1038/leu.2008.257

By:

Murati, A;
Gervais, C;
Carbuccia, N;
Finetti, P;
Cervera, N;
Adélaïde, J;
Struski, S;
Lippert, E;
Mugneret, F;
Tigaud, I;
Penther, D;
Bastard, C;
Poppe, B;
Speleman, F;
Baranger, L;
Luquet, I;
Cornillet-Lefebvre, P;
Nadal, N;
Nguyen-Khac, F;
Pérot, C

Publication type:

Article

Bone marrow microenvironment and the identification of new targets for myeloma therapy.

Published in:

2009

By:

Podar, K;
Chauhan, D;
Anderson, K C

Publication type:

journal article

The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)

Published in:

Leukemia (08876924), 2009, v. 23, n. 1, p. 153, doi. 10.1038/leu.2008.261

By:

Buske, C;
Hoster, E;
Dreyling, M;
Eimermacher, H;
Wandt, H;
Metzner, B;
Fuchs, R;
Bittenbring, J;
Woermann, B;
Hohloch, K;
Hess, G;
Ludwig, W-D;
Schimke, J;
Schmitz, S;
Kneba, M;
Reiser, M;
Graeven, U;
Klapper, W;
Unterhalt, M;
Hiddemann, W

Publication type:

Article

A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease.

Published in:

2009

By:

Best, O G;
Gardiner, A C;
Davis, Z A;
Tracy, I;
Ibbotson, R E;
Majid, A;
Dyer, M J S;
Oscier, D G

Publication type:

Letter

β-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.

Published in:

Leukemia (08876924), 2009, v. 23, n. 1, p. 109, doi. 10.1038/leu.2008.262

By:

Hu, Y;
Chen, Y;
Douglas, L;
Li, S

Publication type:

Article

Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis.

Published in:

Leukemia (08876924), 2009, v. 23, n. 1, p. 170, doi. 10.1038/leu.2008.266

By:

Lwin, T;
Crespo, L A;
Wu, A;
Dessureault, S;
Shu, H B;
Moscinski, L C;
Sotomayor, E;
Dalton, W S;
Tao, J

Publication type:

Article

Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia.

Published in:

2009

By:

Nebral, K;
Denk, D;
Attarbaschi, A;
König, M;
Mann, G;
Haas, O A;
Strehl, S;
König, M

Publication type:

journal article

Constitutive JunB expression, associated with the JAK2 V617F mutation, stimulates proliferation of the erythroid lineage.

Published in:

Leukemia (08876924), 2009, v. 23, n. 1, p. 144, doi. 10.1038/leu.2008.275

By:

da Costa Reis Monte-Mór, B;
Plo, I;
da Cunha, A F;
Costa, G G L;
de Albuquerque, D M;
Jedidi, A;
Villeval, J-L;
Badaoui, S;
Lorand-Metze, I;
Pagnano, K B B;
Saad, S T O;
Vainchenker, W;
Costa, F F

Publication type:

Article

The key role of stem cell factor/KIT signaling in the proliferation of blast cells from Down syndrome-related leukemia.

Published in:

Leukemia (08876924), 2009, v. 23, n. 1, p. 95, doi. 10.1038/leu.2008.267

By:

Toki, T;
Kanezaki, R;
Adachi, S;
Fujino, H;
Xu, G;
Sato, T;
Suzuki, K;
Tauchi, H;
Endo, M;
Ito, E

Publication type:

Article

A bispecific single-chain antibody that mediates target cell-restricted, supra-agonistic CD28 stimulation and killing of lymphoma cells.

Published in:

Leukemia (08876924), 2009, v. 23, n. 1, p. 71, doi. 10.1038/leu.2008.271

By:

Otz, T;
Große-Hovest, L;
Hofmann, M;
Rammensee, H-G;
Jung, G

Publication type:

Article

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.

Published in:

2009

By:

Kyle, R A;
Rajkumar, S V

Publication type:

journal article

Does chemotherapy modify the immune surveillance of hematological malignancies?

Published in:

2009

By:

Barrett, A J;
Savani, B N

Publication type:

journal article

Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia.

Published in:

2009

By:

Kaste, S C;
Thomas, N A;
Rai, S N;
Cheon, K;
McCammon, E;
Chesney, R;
Jones, D;
Pui, C-H;
Hudson, M M

Publication type:

journal article

Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species.

Published in:

2009

By:

Ortiz-Sánchez, E;
Daniels, T R;
Helguera, G;
Martinez-Maza, O;
Bonavida, B;
Penichet, M L;
Ortiz-Sánchez, E

Publication type:

journal article

The NIH consensus criteria for chronic graft-versus-host disease: far more than just another classification.

Published in:

2009

By:

Socié, G

Publication type:

Editorial

Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2009, v. 23, n. 1, p. 125, doi. 10.1038/leu.2008.278

By:

Graux, C;
Stevens-Kroef, M;
Lafage, M;
Dastugue, N;
Harrison, C J;
Mugneret, F;
Bahloula, K;
Struski, S;
Grégoire, M J;
Nadal, N;
Lippert, E;
Taviaux, S;
Simons, A;
Kuiper, R P;
Moorman, A V;
Barber, K;
Bosly, A;
Michaux, L;
Vandenberghe, P;
Lahortiga, I

Publication type:

Article

The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype.

Published in:

Leukemia (08876924), 2009, v. 23, n. 1, p. 117, doi. 10.1038/leu.2008.274

By:

Dicker, F;
Herholz, H;
Schnittger, S;
Nakao, A;
Patten, N;
Wu, L;
Kern, W;
Haferlach, T;
Haferlach, C

Publication type:

Article

CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers.

Published in:

Leukemia (08876924), 2009, v. 23, n. 1, p. 43, doi. 10.1038/leu.2008.299

By:

Burger, J A;
Peled, A

Publication type:

Article

Feasibility of NIH consensus criteria for chronic graft-versus-host disease.

Published in:

Leukemia (08876924), 2009, v. 23, n. 1, p. 78, doi. 10.1038/leu.2008.276

By:

Cho, B-S;
Min, C-K;
Eom, K-S;
Kim, Y-J;
Kim, H-J;
Lee, S;
Cho, S-G;
Kim, D-W;
Lee, J-W;
Min, W-S;
Kim, C-C

Publication type:

Article